Showing results (51-60 of 99) with videos related to
Sort By:
Pageof 10
The American Journal of Medicine|October 14, 2003
Cost-effectiveness of bypass surgery versus stenting in patients with multivessel coronary artery diseaseCynthia A Yock, Derek B Boothroyd, Douglas K Owens, et al.The Journal of Urology|March 23, 2011
Cost-effectiveness analysis of nephron sparing options for the management of small renal massesSteven L Chang, Lauren E Cipriano, Lauren C Harshman, et al.Annals of Surgery|January 25, 2012
Cost-effectiveness of early colectomy with ileal pouch-anal anastamosis versus standard medical therapy in severe ulcerative colitisK T Park, Raymond Tsai, Felipe Perez, et al.Annals of Internal Medicine|May 21, 2014
Health and economic benefits of early vaccination and nonpharmaceutical interventions for a human influenza A (H7N9) pandemic: a modeling studyNayer Khazeni, David W Hutton, Cassandra I F Collins, et al.Archives of Internal Medicine|June 15, 2006
The cost-effectiveness of therapy with teriparatide and alendronate in women with severe osteoporosisHau Liu, Kaleb Michaud, Smita Nayak, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 26, 2018
Approaches to Aggregation and Decision Making-A Health Economics Approach: An ISPOR Special Task Force Report [5]Charles E Phelps, Darius N Lakdawalla, Anirban Basu, et al.American Journal of Public Health|October 3, 2009
Effects of an ongoing epidemic on the annual influenza vaccination rate and vaccination timing among the Medicare elderly: 2000-2005Byung-Kwang Yoo, Megumi Kasajima, Kevin Fiscella, et al.Annals of Internal Medicine|March 3, 2010
Population strategies to decrease sodium intake and the burden of cardiovascular disease: a cost-effectiveness analysisCrystal M Smith-Spangler, Jessie L Juusola, Eva A Enns, et al.American Heart Journal|September 14, 2002
Trends in hospital treatment of ventricular arrhythmias among Medicare beneficiaries, 1985 to 1995Kathryn M McDonald, Mark A Hlatky, Olga Saynina, et al.Journal of Critical Care|November 5, 2003
Cost-effectiveness of recombinant human activated protein C and the influence of severity of illness in the treatment of patients with severe sepsisRobert A Fowler, Marya Hill-Popper, John Stasinos, et al.Pageof 10